Live Breaking News & Updates on நிர்வாகி துணை ப்ரெஸிடெஂட் நுண்ணுயிரியல்

Stay updated with breaking news from நிர்வாகி துணை ப்ரெஸிடெஂட் நுண்ணுயிரியல். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Bruker introduces MBT Sepsityper Kit US IVD


Bruker introduces MBT Sepsityper Kit US IVD for rapid identification of over 400 microorganisms from positive blood cultures
Product News: Bruker introduces MBT Sepsityper Kit US IVD for rapid identification of over 400 microorganisms from positive blood cultures
Used for MALDI Biotyper identification directly from positive blood cultures with short time-to-result of less than 30 minutes
11 Jan 2021
Ike Northern, Director of Infectious Disease Testing and Immunology, CompuNet Clinical Laboratory (Photo: Business Wire)
Bruker Corporation announces US FDA clearance and the US launch of the MBT Sepsityper Kit US IVD for rapid microbial identification of more than 425 microorganisms from positive blood cultures on the MALDI Biotyper CA System. ....

United States , Wolfgang Pusch , Bruker Daltonics , Stevend Burdette , Elisabethc Shearon , Compunet Clinical Laboratory Photo , Compunet Clinical Laboratory In Dayton , Bruker Corporation , Product News , Infectious Disease Testing , Compunet Clinical Laboratory , Business Wire , Executive Vice President Microbiology , Like Northern , Medical Director , Alverno Laboratories , Infectious Diseases , Miami Valley Hospital , Antimicrobial Stewardship , Bruker Introduces Mbt Sepsityper Kit Us Ivd For Rapid Identification Of Over 400 Microorganisms From Positive Blood Cultures Daltonics , ஒன்றுபட்டது மாநிலங்களில் , ஓநாய் தள்ளு , கம்ப்யூட் மருத்துவ ஆய்வகம் புகைப்படம் , கம்ப்யூட் மருத்துவ ஆய்வகம் இல் பகல் , ப்ரூக்கர் நிறுவனம் , ப்ராடக்ட் செய்தி ,

Bruker announces launch of Winter four-plex PCR panel for important respiratory viruses in Europe


Bruker Corporation announced Friday the launch of the
FluoroType SARS-CoV-2/Flu/RSV winter four-plex PCR panel, which enables the sensitive and simultaneous detection of the SARS-CoV-2 virus, of both influenza A and B viruses, as well as of the respiratory syncytial virus (RSV). In the winter season, multiple viruses need to be differentiated in one assay to facilitate diagnosis and patient management.
Image/CDC
The 
FluoroType SARS-CoV-2/Flu/RSV panel is CE-IVD labelled according to European IVD Directive (98/79/EC). It has been validated for nasopharyngeal swabs, oropharyngeal swabs and saliva samples. The kit includes all reagents to generate up to 96 PCR result panels in under two hours after nucleic acid extraction. In evaluations, the sensitivity and specificity from 112 nasopharyngeal or oropharyngeal swabs have achieved 100% for all four viruses with very low limits of detection. In addition, the winter four-plex panel has also been validated with an ....

Wolfgang Pusch , Bruker Daltonics , Health Care Center , Bruker Corporation , Steffi Czieschnek , Medical Healthcare Center , Clinical Chemistry , Executive Vice President Microbiology , ஓநாய் தள்ளு , ஆரோக்கியம் பராமரிப்பு மையம் , ப்ரூக்கர் நிறுவனம் , மருத்துவ சுகாதாரம் மையம் , மருத்துவ வேதியியல் , நிர்வாகி துணை ப்ரெஸிடெஂட் நுண்ணுயிரியல் ,

Bruker Launches FluoroType® SARS-CoV-2/Flu/RSV PCR Panel in Europe with CE-IVD Mark


Published: Dec 18, 2020
NEHREN, Germany (BUSINESS WIRE) Bruker Corporation (Nasdaq: BRKR) today announced the launch of the
FluoroType SARS-CoV-2/Flu/RSV winter four-plex PCR panel, which enables the sensitive and simultaneous detection of the SARS-CoV-2 virus, of both influenza A and B viruses, as well as of the respiratory syncytial virus (RSV). In the winter season, multiple viruses need to be differentiated in one assay to facilitate diagnosis and patient management.
Figure 1: FluoroType SARS-CoV-2/Flu/RSV Test Kit (Photo: Business Wire)
The
FluoroType SARS-CoV-2/Flu/RSV panel is CE-IVD labelled according to European IVD Directive (98/79/EC). It has been validated for nasopharyngeal swabs, oropharyngeal swabs and saliva samples. The kit includes all reagents to generate up to 96 PCR result panels in under two hours after nucleic acid extraction. In evaluations, the sensitivity and specificity from 112 nasopharyngeal or oropharyngeal swabs have achie ....

Wolfgang Pusch , Bruker Daltonics , Hain Lifescience Gmb , Health Care Center , Bruker Corporation Nasdaq , Business Wire , Steffi Czieschnek , Medical Healthcare Center , Clinical Chemistry , Executive Vice President Microbiology , Hain Diagnostics , Molecular Diagnostics , Lifescience Gmbh , Bruker Corporation , ஓநாய் தள்ளு , ஹெய்ன் ஆயுள் அறிவியல் க்ம்ப் , ஆரோக்கியம் பராமரிப்பு மையம் , ப்ரூக்கர் நிறுவனம் நாஸ்டாக் , வணிக கம்பி , மருத்துவ சுகாதாரம் மையம் , மருத்துவ வேதியியல் , நிர்வாகி துணை ப்ரெஸிடெஂட் நுண்ணுயிரியல் , ஹெய்ன் பரிசோதனை , மூலக்கூறு பரிசோதனை , ஆயுள் அறிவியல் கஂப் , ப்ரூக்கர் நிறுவனம் ,